Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: JACC Heart Fail. 2015 Sep;3(9):715–723. doi: 10.1016/j.jchf.2015.03.015

Figure 4. In vitro cyclic GMP response of synthetic peptides.

Figure 4

GC-A (A) or GC-B (B) expressing HEK293 cells were treated with or without10−8 to 10−6 M of proANP, ANP, BNP or CNP for 10 min. *p<0.05 vs no treatment, †p<0.05 vs equimolar dose of BNP, and ‡p<0.05 vs equimolar dose of ANP.